US Bancorp’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$92.9K Buy
2,797
+204
+8% +$6.08K ﹤0.01% 2427
2025
Q4
$77.3K Sell
2,593
-37
-1% -$1.21K ﹤0.01% 2497
2025
Q3
$95K Sell
2,630
-518
-16% -$17.1K ﹤0.01% 2372
2025
Q2
$113K Sell
3,148
-685
-18% -$25.5K ﹤0.01% 2364
2025
Q1
$151K Buy
3,833
+15
+0.4% +$505 ﹤0.01% 2172
2024
Q4
$115K Sell
3,818
-986
-21% -$28.3K ﹤0.01% 2326
2024
Q3
$112K Sell
4,804
-24
-0.5% -$524 ﹤0.01% 2340
2024
Q2
$85.9K Sell
4,828
-1,402
-23% -$22.4K ﹤0.01% 2411
2024
Q1
$94.8K Buy
6,230
+1,143
+22% +$18.2K ﹤0.01% 2394
2023
Q4
$86.9K Buy
5,087
+4,650
+1,064% +$54K ﹤0.01% 2408
2023
Q3
$3.65K Sell
437
-9,276
-96% -$129K ﹤0.01% 3522
2023
Q2
$241K Buy
9,713
+7,363
+313% +$190K ﹤0.01% 1773
2023
Q1
$35.3K Sell
2,350
-20,348
-90% -$309K ﹤0.01% 2690
2022
Q4
$269K Buy
22,698
+19,432
+595% +$141K ﹤0.01% 1707
2022
Q3
$19K Buy
3,266
+1,978
+154% +$13K ﹤0.01% 3050
2022
Q2
$5K Sell
1,288
-170
-12% -$1.06K ﹤0.01% 3607
2022
Q1
$14K Buy
1,458
+1,074
+280% +$12.4K ﹤0.01% 3263
2021
Q4
$7K Sell
384
-38
-9% -$987 ﹤0.01% 3555
2021
Q3
$14K Sell
422
-13,130
-97% -$406K ﹤0.01% 3307
2021
Q2
$525K Buy
13,552
+88
+0.7% +$3.46K ﹤0.01% 1534
2021
Q1
$649K Buy
13,464
+703
+6% +$33.8K ﹤0.01% 1368
2020
Q4
$664K Buy
+12,761
New +$431K ﹤0.01% 1291
2016
Q2
Sell
-5,020
Closed -$43K 3634
2016
Q1
$43K Hold
5,020
﹤0.01% 2452
2015
Q4
$60K Hold
5,020
﹤0.01% 2354
2015
Q3
$51K Sell
5,020
-60
-1% -$894 ﹤0.01% 2448
2015
Q2
$84K Sell
5,080
-4,430
-47% -$70.1K ﹤0.01% 2260
2015
Q1
$147K Sell
9,510
-115
-1% -$1.74K ﹤0.01% 1924
2014
Q4
$152K Sell
9,625
-1,150
-11% -$15K ﹤0.01% 1897
2014
Q3
$115K Hold
10,775
﹤0.01% 2032
2014
Q2
$101K Buy
+10,775
New +$68.9K ﹤0.01% 2121

Other funds holding TGTX